These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33535327)

  • 41. Fungal pulmonary complications.
    Davies SF; Sarosi GA
    Clin Chest Med; 1996 Dec; 17(4):725-44. PubMed ID: 9016374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rare Case: Invasive Pseudomembranous Aspergillus Tracheobronchitis in a Postpartum Patient Presenting With Stridor.
    Shah M; Singhal P
    J Bronchology Interv Pulmonol; 2015 Jul; 22(3):248-50. PubMed ID: 26165896
    [No Abstract]   [Full Text] [Related]  

  • 43. [Diagnosis and treatment of invasive pulmonary aspergillosis in children: how to use the guideline for diagnosis and treatment of pediatric invasive pulmonary fungal infections (2009)].
    Deng L; Yin GQ
    Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):475-7. PubMed ID: 19951483
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of fungal lung disease in the immunocompromised.
    Islam A; Mody CH
    Ther Adv Respir Dis; 2011 Oct; 5(5):305-24. PubMed ID: 21807757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic necrotizing pulmonary aspergillosis.
    Lo CH; Wu SW
    QJM; 2014 Jul; 107(7):587. PubMed ID: 24259718
    [No Abstract]   [Full Text] [Related]  

  • 46. Current and future therapies for invasive aspergillosis.
    Bassetti M; Pecori D; Della Siega P; Corcione S; De Rosa FG
    Pulm Pharmacol Ther; 2015 Jun; 32():155-65. PubMed ID: 24994691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pulmonary aspergilloma: considerations on a case with bilateral multiple localizations].
    Rossi GA; Cerri E; Quaglia R
    Arch Maragliano Patol Clin; 1978; 34(1):71-4. PubMed ID: 583621
    [No Abstract]   [Full Text] [Related]  

  • 48. Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
    Escribano P; Muñoz P; Montilla P; Padilla B; Bouza E; Guinea J
    J Clin Microbiol; 2017 Jan; 55(1):331-333. PubMed ID: 27795351
    [No Abstract]   [Full Text] [Related]  

  • 49. [Diagnosis and treatment of pulmonary fungal infection in intensive care unit].
    Chen YH; Yao WZ; Wang JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):197-200. PubMed ID: 15130334
    [No Abstract]   [Full Text] [Related]  

  • 50. A practical critique of antifungal treatment guidelines for haemato-oncologists.
    Agrawal S; Jones B; Barnes R; Kibbler C; Millen M; Ashcroft M; Jain S; Last A; Lewis D; Lewis T; Patel M; Pagliuca A
    Crit Rev Microbiol; 2012 Aug; 38(3):203-16. PubMed ID: 22324737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Birefringent crystals in a lung cavity.
    Harigopal P; Bejarano P; Burke G; Dowdy LM
    Clin Infect Dis; 2005 Jun; 40(12):1806, 1849-50. PubMed ID: 15912600
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fluconazole treatment of systemic mycoses].
    Mori T; Matsumura M; Ebe T; Takahashi M; Kohara T; Inagaki M; Isonuma H; Hibiya I; Hamamoto T; Watanabe K
    Jpn J Antibiot; 1989 Jan; 42(1):55-62. PubMed ID: 2540368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient.
    Cabanes L; Plaza P; Martinez Moragón E
    Med Clin (Barc); 2018 Jun; 150(11):451. PubMed ID: 29179893
    [No Abstract]   [Full Text] [Related]  

  • 54. An "alternative" clinical course of COPD exacerbation and pulmonary embolism.
    Terzano C; Conti V; Petroianni A; Paone G
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3341-6. PubMed ID: 24379066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invasive pulmonary aspergillosis in patients with severe influenza.
    Irfan M; Jabeen K; Hussain M; Farooqi J; Rashid NH; Nasir N; Hasan Z
    Int J Tuberc Lung Dis; 2020 Nov; 24(11):1205-1207. PubMed ID: 33172529
    [No Abstract]   [Full Text] [Related]  

  • 56. [Curative antifungal treatment of invasive pulmonary aspergillosis].
    Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
    Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarkers of fungal lung infection.
    Paiva JA; Pereira JM
    Curr Opin Infect Dis; 2019 Apr; 32(2):136-142. PubMed ID: 30640821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disseminated invasive aspergillosis successfully treated with micafungin in a renal transplant recipient.
    Wadi J; Al-kawasmeh SI; Kamel MT; AlJayyousi BB
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):914-8. PubMed ID: 20814131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary aspergillosis complicating aplastic phase in hematologic patients.
    Capnist G; Chisesi T; Battista R; Dini E
    Haematologica; 1986; 71(3):201-4. PubMed ID: 3093323
    [No Abstract]   [Full Text] [Related]  

  • 60. Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.
    Jacobs SE; Wengenack NL; Walsh TJ
    Semin Respir Crit Care Med; 2020 Feb; 41(1):115-130. PubMed ID: 32000288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.